Medicare will soon cover obesity drugs, but many seniors may not know
Injection pens for the weight loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news…
The Race to Build the Next Generation of Weight Loss Pills Is Heating Up
The future of weight loss treatment is looking to get easier to swallow. Several research teams and pharmaceutical…
Definium LSD therapy for major depression helped patients in Phase 3 trial
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Shocking side effect of blood pressure medication sent woman to ER
Earlier this month, an Illinois woman named Lily woke up with a sore on her lip and thought…
2026 pharma and biotech deal-making already tops 2025 total
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of…
FDA pilot program aims to speed up early-stage clinical trials
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
Eli Lilly ends 340B drug discounts to some hospitals over missing claims data
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
FDA approves Colorado’s plan to import cheaper drugs from Canada
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
Centre bans 16 irrational fixed-dose drug combinations
The Union Health Ministry has banned the manufacture, sale and distribution of 16 fixed-dose combination (FDC) drugs for…
Two habits beat out diabetes wonder drug metaformin: study
A buzzy diabetes drug that’s been hailed as a longevity booster may have some competition. The decades-old medication…
Centene to offer buyouts to some employees
Sheldon Cooper | Lightrocket | Getty Images Centene said it offered buyouts to some employees on Monday, as…
Analysis: Shortage of many medicines in the U.S. remains a ‘systemic’ problem
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…